Immunopharmacokinetics of synthetic beta-carotene | 
 
|
| Sergeev A.V., Anan'ev V.S., Vakulova L.A., Zhidkova T.A., Mukhammedzhanov S.K., Ramanauskaĭte R.Yu., Tolkachev V.N. | | PubMed Id: 1298123 | | Year: 1992 vol: 38 issue:6 pages: 27-29 | | Abstract: The immunopharmacology and pharmacokinetics of synthetic beta-carotene were studied in complex clinico-laboratory investigations after single and repeated per os administrations of various doses of the drug to healthy volunteers and cancer patients. Repeated treatment with beta-carotene at a dose of 30 mg caused no significant changes in the immunological parameters studied. However, treatment with a dose of 250 mg altered the parameters as follows: alteration of beta-carotene content in blood, elevation of the counts of lymphocytes and T lymphocytes forming 'active' rosettes, increase in the proliferative response of lymphocytes to the mitogen PWM and activation of natural killers. Single administration of the drug in a dose of 1,000 and 2,000 mg led to short-term reversible immunodepression, appeared as leukopenia, abolition of the proliferative response of lymphocytes to mitogens and inhibition of T suppressors. Kinetics of retinoids and beta-carotene content in blood plasma was studied after single per os administration of drug megadoses. | | Download PDF: | | Reference: Sergeev A.V., Anan'ev V.S., Vakulova L.A., Zhidkova T.A., Mukhammedzhanov S.K., Ramanauskaĭte R.Yu., Tolkachev V.N., Immunopharmacokinetics of synthetic beta-carotene, Voprosy meditsinskoi khimii, 1992, vol: 38(6), 27-29. | |
References
|
| |
